Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700020345

Trial Profile

Clinical Trials Insight: 700020345

Phase of Trial: Phase I

Latest Information Update: 21 Sep 2009

At a glance

  • Drugs AEZS 112 (Primary)
  • Indications Lymphoma; Solid tumours
  • Focus Adverse reactions
  • Sponsors AEterna Zentaris Inc
  • Most Recent Events

    • 21 Sep 2009 Results have been reported by Aterna Zentaris in a media release.
    • 21 Sep 2009 Status changed from active, no longer recruiting to completed, according to an Aterna media release.
    • 22 Apr 2009 Interim results presented at the 100th Annual Meeting of the American Association for Cancer Research (AACR-2009).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top